Home › Esophageal Adenocarcinoma › Arkansas
Esophageal Adenocarcinoma clinical trials in Arkansas
4 studies for Esophageal Adenocarcinoma are looking for participants at sites in Arkansas.
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
- Baptist Health Medical Center - Little Rock, Little Rock
- University of Arkansas for Medical Sciences, Little Rock
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT06203600Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Research Site, Springdale
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07431281mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- Mercy Hospital Fort Smith, Fort Smith
- CARTI Cancer Center, Little Rock
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT05677490A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Highlands Oncology Group, Fayetteville
- Highlands Oncology Group, Rogers
- Highlands Oncology Group, Springdale
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 6, 2026 · NCT04389632From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.